Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,404 | -25,661 | -28,073 | 2,097 | -28,992 |
| Depreciation Amortization | 1,835 | 1,800 | 907 | 821 | 803 |
| Accounts receivable | 272 | 2,125 | 19,171 | -23,250 | 366 |
| Other Working Capital | 17,268 | -206 | 52,805 | -12,180 | 1,654 |
| Other Operating Activity | -4,242 | -6,319 | -19,972 | 22,620 | -79 |
| Operating Cash Flow | $-24,271 | $-28,261 | $24,838 | $-9,892 | $-26,247 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,000 | -3,466 | -21,342 | -12,192 | 0 |
| PPE Investments | -200 | -2,053 | -4,944 | -1,076 | -250 |
| Investing Cash Flow | $9,800 | $-5,519 | $-26,286 | $-13,268 | $-250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 5,300 | 2,000 | 407 | N/A |
| Debt Repayment | -1,390 | -3,106 | -805 | -1,191 | -2,363 |
| Common Stock Issued | 48,527 | 29,385 | 11,912 | 40,837 | 24 |
| Other Financing Activity | 41 | 0 | 0 | 0 | 612 |
| Financing Cash Flow | $47,178 | $31,579 | $13,107 | $40,053 | $-1,727 |
| Beginning Cash Position | 51,202 | 53,403 | 41,744 | 24,851 | 53,075 |
| End Cash Position | 83,909 | 51,202 | 53,403 | 41,744 | 24,851 |
| Net Cash Flow | $32,707 | $-2,201 | $11,659 | $16,893 | $-28,224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,271 | -28,261 | 24,838 | -9,892 | -26,247 |
| Capital Expenditure | -200 | -2,053 | -4,944 | -1,076 | -250 |
| Free Cash Flow | -24,471 | -30,314 | 19,894 | -10,968 | -26,497 |